Revvity Net Income 2012-2025 | RVTY
Revvity annual/quarterly net income history and growth rate from 2012 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
- Revvity net income for the quarter ending September 30, 2025 was $0.047B, a 50.56% decline year-over-year.
- Revvity net income for the twelve months ending September 30, 2025 was $0.237B, a 6.61% decline year-over-year.
- Revvity annual net income for 2024 was $0.27B, a 60.99% decline from 2023.
- Revvity annual net income for 2023 was $0.693B, a 21.77% increase from 2022.
- Revvity annual net income for 2022 was $0.569B, a 39.65% decline from 2021.
|
Revvity Annual Net Income (Millions of US $) |
|
|---|---|
| 2024 | $270 |
| 2023 | $693 |
| 2022 | $569 |
| 2021 | $943 |
| 2020 | $728 |
| 2019 | $228 |
| 2018 | $238 |
| 2017 | $293 |
| 2016 | $234 |
| 2015 | $212 |
| 2014 | $158 |
| 2013 | $167 |
| 2012 | $70 |
| 2011 | $8 |
|
Revvity Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2025-09-30 | $47 |
| 2025-06-30 | $54 |
| 2025-03-31 | $42 |
| 2024-12-31 | $95 |
| 2024-09-30 | $94 |
| 2024-06-30 | $55 |
| 2024-03-31 | $26 |
| 2023-12-31 | $79 |
| 2023-09-30 | $9 |
| 2023-06-30 | $36 |
| 2023-03-31 | $569 |
| 2022-12-31 | $128 |
| 2022-09-30 | $85 |
| 2022-06-30 | $179 |
| 2022-03-31 | $177 |
| 2021-12-31 | $190 |
| 2021-09-30 | $128 |
| 2021-06-30 | $246 |
| 2021-03-31 | $379 |
| 2020-12-31 | $380 |
| 2020-09-30 | $177 |
| 2020-06-30 | $137 |
| 2020-03-31 | $34 |
| 2019-12-31 | $65 |
| 2019-09-30 | $59 |
| 2019-06-30 | $69 |
| 2019-03-31 | $35 |
| 2018-12-31 | $71 |
| 2018-09-30 | $77 |
| 2018-06-30 | $64 |
| 2018-03-31 | $26 |
| 2017-12-31 | $-41 |
| 2017-09-30 | $91 |
| 2017-06-30 | $204 |
| 2017-03-31 | $39 |
| 2016-12-31 | $65 |
| 2016-09-30 | $58 |
| 2016-06-30 | $64 |
| 2016-03-31 | $47 |
| 2015-12-31 | $68 |
| 2015-09-30 | $55 |
| 2015-06-30 | $49 |
| 2015-03-31 | $40 |
| 2014-12-31 | $31 |
| 2014-09-30 | $42 |
| 2014-06-30 | $50 |
| 2014-03-31 | $34 |
| 2013-12-31 | $67 |
| 2013-09-30 | $40 |
| 2013-06-30 | $28 |
| 2013-03-31 | $32 |
| 2012-12-31 | $-16 |
| 2012-09-30 | $30 |
| 2012-06-30 | $34 |
| 2012-03-31 | $23 |
| 2011-12-31 | $-84 |
| 2011-09-30 | $37 |
| 2011-06-30 | $30 |
| 2011-03-31 | $25 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $13.350B | $2.755B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $169.580B | 31.14 |
| HCA Healthcare (HCA) | United States | $106.416B | 17.62 |
| CVS Health (CVS) | United States | $104.957B | 12.07 |
| Elevance Health (ELV) | United States | $82.726B | 12.13 |
| Cencora (COR) | United States | $68.377B | 22.04 |
| Natera (NTRA) | United States | $33.600B | 0.00 |
| DiDi Global (DIDIY) | China | $23.532B | 21.74 |
| Labcorp Holdings (LH) | United States | $22.381B | 17.07 |
| Medpace Holdings (MEDP) | United States | $17.078B | 42.40 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.157B | 0.00 |
| Viatris (VTRS) | United States | $15.249B | 5.68 |
| ICON (ICLR) | Ireland | $15.081B | 14.96 |
| BioMerieux (BMXMF) | France | $14.360B | 0.00 |
| Solventum (SOLV) | United States | $13.921B | 13.51 |
| CochLear (CHEOY) | Australia | $12.343B | 0.00 |
| Charles River Laboratories (CRL) | United States | $11.026B | 21.24 |
| Avantor (AVTR) | United States | $8.345B | 12.75 |
| Sonic Healthcare (SKHHY) | Australia | $7.987B | 0.00 |
| HealthEquity (HQY) | United States | $7.383B | 27.61 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.209B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $7.142B | 42.58 |
| Bausch + Lomb (BLCO) | Canada | $6.089B | 39.98 |
| PACS (PACS) | United States | $5.503B | 33.47 |
| Sotera Health (SHC) | United States | $5.369B | 25.89 |
| Alignment Healthcare (ALHC) | United States | $4.724B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $2.945B | 51.72 |
| Concentras Parent (CON) | United States | $2.785B | 17.38 |
| Organon (OGN) | United States | $2.532B | 2.67 |
| Progyny (PGNY) | United States | $2.155B | 42.37 |
| Surgery Partners (SGRY) | United States | $2.044B | 26.33 |
| Establishment Labs Holdings (ESTA) | United States | $1.960B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.907B | 11.39 |
| Ardent Health (ARDT) | United States | $1.236B | 4.03 |
| Nutex Health (NUTX) | United States | $1.127B | 8.62 |
| Teladoc Health (TDOC) | United States | $1.127B | 0.00 |
| CareDx (CDNA) | United States | $1.081B | 17.66 |
| Omada Health (OMDA) | United States | $0.930B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.872B | 14.28 |
| InnovAge Holding (INNV) | United States | $0.806B | 0.00 |
| Embecta (EMBC) | United States | $0.715B | 4.07 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.685B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.596B | 0.00 |
| Enhabit (EHAB) | United States | $0.560B | 25.16 |
| CryoPort (CYRX) | United States | $0.547B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.489B | 0.00 |
| SBC Medicals (SBC) | United States | $0.459B | 8.43 |
| Auna S.A (AUNA) | Luxembourg | $0.419B | 6.74 |
| Agilon Health (AGL) | United States | $0.419B | 0.00 |
| Oncology Institute (TOI) | United States | $0.353B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.311B | 65.42 |
| Shoulder Innovations (SI) | United States | $0.310B | 0.00 |
| So-Young (SY) | China | $0.300B | 0.00 |
| Beauty Health (SKIN) | United States | $0.199B | 0.00 |
| KindlyMD (NAKA) | United States | $0.177B | 0.00 |
| LifeMD (LFMD) | United States | $0.174B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.133B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.131B | 0.00 |
| Biodesix (BDSX) | United States | $0.088B | 0.00 |
| DocGo (DCGO) | United States | $0.083B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.079B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.045B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.044B | 0.00 |
| Pomdoctor - (POM) | China | $0.030B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.021B | 6.55 |
| OSR Holdings (OSRH) | United States | $0.020B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.015B | 0.00 |
| Lifeward (LFWD) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |